1. Home
  2. PACS vs TMDX Comparison

PACS vs TMDX Comparison

Compare PACS & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PACS
  • TMDX
  • Stock Information
  • Founded
  • PACS 2013
  • TMDX 1998
  • Country
  • PACS United States
  • TMDX United States
  • Employees
  • PACS N/A
  • TMDX N/A
  • Industry
  • PACS
  • TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PACS
  • TMDX Health Care
  • Exchange
  • PACS Nasdaq
  • TMDX Nasdaq
  • Market Cap
  • PACS 2.1B
  • TMDX 2.1B
  • IPO Year
  • PACS 2024
  • TMDX 2019
  • Fundamental
  • Price
  • PACS $13.81
  • TMDX $57.20
  • Analyst Decision
  • PACS Strong Buy
  • TMDX Buy
  • Analyst Count
  • PACS 9
  • TMDX 11
  • Target Price
  • PACS $33.22
  • TMDX $116.10
  • AVG Volume (30 Days)
  • PACS 602.3K
  • TMDX 2.6M
  • Earning Date
  • PACS 02-16-2025
  • TMDX 02-24-2025
  • Dividend Yield
  • PACS N/A
  • TMDX N/A
  • EPS Growth
  • PACS 82.79
  • TMDX N/A
  • EPS
  • PACS 0.68
  • TMDX 0.94
  • Revenue
  • PACS $3,558,953,000.00
  • TMDX $401,090,000.00
  • Revenue This Year
  • PACS $29.04
  • TMDX $81.61
  • Revenue Next Year
  • PACS $18.31
  • TMDX $22.52
  • P/E Ratio
  • PACS $20.30
  • TMDX $61.04
  • Revenue Growth
  • PACS 205.08
  • TMDX 109.09
  • 52 Week Low
  • PACS $12.54
  • TMDX $56.03
  • 52 Week High
  • PACS $43.92
  • TMDX $177.37
  • Technical
  • Relative Strength Index (RSI)
  • PACS N/A
  • TMDX 35.74
  • Support Level
  • PACS N/A
  • TMDX $58.40
  • Resistance Level
  • PACS N/A
  • TMDX $67.80
  • Average True Range (ATR)
  • PACS 0.00
  • TMDX 4.59
  • MACD
  • PACS 0.00
  • TMDX -0.27
  • Stochastic Oscillator
  • PACS 0.00
  • TMDX 4.44

About PACS PACS Group Inc. Common Stock

PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.

About TMDX TransMedics Group Inc.

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Share on Social Networks: